These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32099365)
21. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment. Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881 [TBL] [Abstract][Full Text] [Related]
22. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722 [TBL] [Abstract][Full Text] [Related]
23. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790 [TBL] [Abstract][Full Text] [Related]
24. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Wang Y; Yu L; Han L; Sha X; Fang X Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311 [TBL] [Abstract][Full Text] [Related]
25. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661 [TBL] [Abstract][Full Text] [Related]
26. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
28. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
29. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro. Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492 [TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies. Wang X; Chen Q; Zhang X; Ren X; Zhang X; Meng L; Liang H; Sha X; Fang X Int J Nanomedicine; 2018; 13():4641-4659. PubMed ID: 30147314 [TBL] [Abstract][Full Text] [Related]
31. Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo. Zhu Y; Wang X; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2017 Mar; 250():9-19. PubMed ID: 28163212 [TBL] [Abstract][Full Text] [Related]
32. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123. Han LM; Guo J; Zhang LJ; Wang QS; Fang XL Acta Pharmacol Sin; 2006 Jun; 27(6):747-53. PubMed ID: 16723095 [TBL] [Abstract][Full Text] [Related]
34. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel. Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319 [TBL] [Abstract][Full Text] [Related]
35. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system. Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930 [TBL] [Abstract][Full Text] [Related]
37. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Chen Y; Sha X; Zhang W; Zhong W; Fan Z; Ren Q; Chen L; Fang X Int J Nanomedicine; 2013; 8():1463-76. PubMed ID: 23620663 [TBL] [Abstract][Full Text] [Related]
38. Engineering a pH-responsive polymeric micelle co-loaded with paclitaxel and triptolide for breast cancer therapy. Zhang M; Ying N; Chen J; Wu L; Liu H; Luo S; Zeng D Cell Prolif; 2024 Jun; 57(6):e13603. PubMed ID: 38228366 [TBL] [Abstract][Full Text] [Related]
39. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study. Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554 [TBL] [Abstract][Full Text] [Related]
40. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model. Piao L; Li Y; Zhang H; Jiang J J Biomater Sci Polym Ed; 2019 Feb; 30(3):233-246. PubMed ID: 30606090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]